Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy

被引：0
|
作者：
Hazim, A. [1 ]
Xiao, A. [1 ]
Singh, A. [1 ]
Chung, K. [2 ]
dos Santos, P. A. Reck [2 ]
D'Cunha, J. [2 ]
Shanshal, M. [1 ]
Dimou, A. [1 ]
Parikh, K. [1 ]
Lou, Y. [3 ]
Manochakian, R. [3 ]
Leventakos, K. [1 ]
Molina, J. [1 ]
Mansfield, A. [1 ]
Ernani, V. [2 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Mayo Clin, Jacksonville, FL 32224 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
chemoimmunotherapy; neoadjuvant; non small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.07C.16
引用
收藏
页码：S546 / S547
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant therapy in early-stage non-small cell lung cancer: A real-world analysis
    Ay, Leyla
    Steiner, Daniel
    Fabikan, Hannah
    Illini, Oliver
    Krenbek, Dagmar
    Klikovits, Thomas
    Benej, Michal
    Kirchbacher, Klaus
    Watzka, Stefan
    Valipour, Arschang
    Hochmair, Maximilian
    LUNG CANCER, 2024, 198
  • [2] Neoadjuvant Chemoimmunotherapy (CIT) In Resectable Non-Small Cell Lung Cancer (NSCLC): Real-World Treatment Patterns and Surgical Outcomes
    Gibson, A. J.
    Dean, M. L.
    Litt, I.
    Navani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S543 - S543
  • [3] A real-world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non-small cell lung cancer
    Zhang, Baihua
    Xiao, Haifan
    Pu, Xingxiang
    Zhou, Chunhua
    Yang, Desong
    Li, Xu
    Wang, Wenxiang
    Xiao, Qin
    CANCER MEDICINE, 2023, 12 (01): : 274 - 286
  • [4] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Laura Gutierrez-Sainz
    Patricia Cruz-Castellanos
    Oliver Higuera
    Javier de Castro-Carpeño
    Current Treatment Options in Oncology, 2021, 22
  • [5] Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
    Gutierrez-Sainz, Laura
    Cruz-Castellanos, Patricia
    Higuera, Oliver
    De Castro-Carpeno, Javier
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)
  • [6] Comparison of neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable stage III non-small cell lung cancer: a real-world cohort study
    Zhou, Sihao
    Liu, Yi
    Liu, Kejun
    Zhang, Junkai
    Liang, Hanlin
    Wu, Yingmeng
    Ye, Hongyu
    Liang, Yi
    Zhang, Jingjing
    Huang, Weizhao
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [7] Real-world outcomes in patients with biomarker-selected early-stage non-small cell lung cancer
    Abu Rous, Fawzi
    Sussell, Jesse
    Ngiam, Celina
    Zhang, Qing
    Majda, Thomas
    Sheinson, Daniel
    Ogale, Sarika
    Bara, Ilze
    Schulze, Katja
    Gadgeel, Shirish M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Xu, Feng
    Hui, Zhenzhen
    Zhao, Gang
    Liu, Jie
    Zhang, Huan
    Zeng, Ziqing
    Zhang, Ran
    Provencio, Mariano
    Ren, Xiubao
    You, Jian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2193 - +
  • [9] Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer
    Hu, Yan
    Ren, Si-Ying
    Wang, Ruo-Yao
    Zeng, Chao
    Li, Ji-Na
    Xiao, Peng
    Wu, Fang
    Yu, Feng-Lei
    Liu, Wen-Liang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Neoadjuvant therapy in resectable non-stage IV non-small cell lung cancer: real-world analysis
    Ay, L.
    Fabikan, H.
    Steiner, D.
    Illini, O.
    Krenbek, D.
    Klikovits, T.
    Lang-Stoeberl, A.
    Mueser, N.
    Kirchbacher, K.
    Funk, G. C.
    Watzka, S.
    Valipour, A.
    Hochmair, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S533 - S533
12345